Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Pancreatic cancer
Stage/Subtype:  stage I pancreatic cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-25 of 32 for your search:
Start Over
Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: CDM00047339, NCI-2016-00348, E7059, NCT01774019
Surgery With or Without Intraperitoneal Drainage in Improving Complication Rate in Patients With Pancreatic Disease
Status: Active
Phase: Phase III
Type: Health services research, Treatment
Age: 18 and over
Trial IDs: H-28324, NCI-2012-01881, NCT01441492
Stereotactic Body Radiation Therapy in Treating Patients with Pancreatic or Ampulla of Vater Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 16866B, NCI-2015-01656, NCT01342354
Multi-tracer PET/CT in Predicting and Assessing Response in Patients with Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer Receiving Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 18 and over
Trial IDs: HCI74163, NCI-2014-02370, 74163, NCI-2014-02286, NCT02245217
Vaccine Therapy and Cyclophosphamide in Treating Patients with Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: J09100, NCI-2010-01868, CIR00005394, NA_00031401, NCT01088789
Stereotactic Radiosurgery in Treating Patients with Pancreatic Cancer That Has Been Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-123, NCI-2014-01951, NCI-2014-01140, NCT01357525
Proton or Photon Beam Radiation Therapy, Capecitabine, and Hydroxychloroquine in Treating Patients with Pancreatic Cancer That Can Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-073, NCI-2012-00148, NCT01494155
Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients with Pancreatic Cancer That May Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UMCC 2011.007, NCI-2012-01916, HUM00047389, HUM 47389, NCT01661088
Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Hydroxychloroquine Before Surgery in Treating Patients With Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UPCI 13-074, NCI-2013-02230, NCT01978184
Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment
Age: 18 and over
Trial IDs: 1306012255, NCI-2013-02349, NCT02047474
Gemcitabine Hydrochloride and Nab-Paclitaxel or mFOLFIRINOX with Stereotactic Body Radiation Therapy before Surgery in Treating Patients with Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: UPCI# 13-143, NCI-2014-02046, PRO13120167, NCT02241551
Gemcitabine Hydrochloride, Ascorbic Acid, and Radiation Therapy in Treating Patients with Pancreatic Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 201310772, NCI-2014-00824, GAX-PAN-I, NCT01852890
Stereotactic Body Radiation Therapy and Capecitabine before Surgery in Treating Patients with Pancreatic Cancer That Can Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: RO-12210, NCI-2013-01347, 2013-0645, NCT01918644
Radiation Therapy and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients with Pancreatic Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 32213, NCI-2015-00393, NCI-2014-01794, 819437, NCT02207465
INO-1400 Vaccine Alone or in Combination with INO-9012 Followed by Electroporation in Treating Patients with Breast, Lung, or Pancreatic Cancer at High Risk of Relapse after Surgery and Standard Treatment
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCC #22913 / Inovio TRT-00, NCI-2015-00389, UPCC 22913, 821038, NCT02327468
Sorafenib Tosylate, Vorinostat, Gemcitabine Hydrochloride, and Radiation Therapy in Treating Patients with Pancreatic Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MCC-12-07328, NCI-2015-00017, NCT02349867
Stereotactic Body Radiation Therapy in Treating Patients with Pancreatic Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 140103, NCI-2014-01502, UCSD 140103, NCT02454140
RO7009789 with or without Nab-paclitaxel and Gemcitabine Hydrochloride before and after Surgery in Treating Patients with Newly Diagnosed Pancreatic Cancer That Can Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UPCC 20214, NCI-2015-00537, CITN11-01, NCT02588443
Whipple at the Splenic Artery (WATSA)
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 to 69
Trial IDs: 201105335 (10-0767), NCI-2011-00264, NCT01155882
Gemcitabine Hydrochloride During Surgery in Treating Patients with Pancreatic Cancer That Can Be Removed by Surgery
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2010-0371, NCI-2011-00244, NCT01276613
Start Over